$LumiraDx (LMDXF.US)$
This is a long one folks... should answer most of our questions.
The "Twilight Window" and the "End is Nigh" deadline represent the final legal threshold for LumiraDx Limited to transition from a dissolved state to a functional successor via ElectraDx. Under Cayman Grand Court Companies Act Section 159 and the court’s Inherent Jurisdiction, a company dissolved after a court-ordered winding up (as occurred on September 17, 2024) is generally beyond the...
This is a long one folks... should answer most of our questions.
The "Twilight Window" and the "End is Nigh" deadline represent the final legal threshold for LumiraDx Limited to transition from a dissolved state to a functional successor via ElectraDx. Under Cayman Grand Court Companies Act Section 159 and the court’s Inherent Jurisdiction, a company dissolved after a court-ordered winding up (as occurred on September 17, 2024) is generally beyond the...
7
5
$LumiraDx (LMDXF.US)$
Know it alls must actually "know it all" So to the ST stuck short warriors that speak poorly to longs this is for you. We all know who they are...
We must look objectively at why this "zombie ticker" persists despite the Cayman dissolution order, as the intersection of Cayman Insolvency Law and U.S. Market Mechanics suggests a pathway that is more than mere speculation. While the Grand Court of the Cayman Islands issued a dissolution order in September 20...
Know it alls must actually "know it all" So to the ST stuck short warriors that speak poorly to longs this is for you. We all know who they are...
We must look objectively at why this "zombie ticker" persists despite the Cayman dissolution order, as the intersection of Cayman Insolvency Law and U.S. Market Mechanics suggests a pathway that is more than mere speculation. While the Grand Court of the Cayman Islands issued a dissolution order in September 20...
7
1
$LumiraDx (LMDXF.US)$
This is just to show the stuck shorts the legal process, since they are unable to research Cayman Law. Just do not like the tone they use with you guys... and the constant insults to shareholders looking for a path to their recovery.
Here is the definitive legal roadmap for a potential reorganization between the original LumiraDx shareholders and ElectraDx.
To execute a reverse merger, the defunct parent company, LumiraDx Limited (Cayman Islands), mus...
This is just to show the stuck shorts the legal process, since they are unable to research Cayman Law. Just do not like the tone they use with you guys... and the constant insults to shareholders looking for a path to their recovery.
Here is the definitive legal roadmap for a potential reorganization between the original LumiraDx shareholders and ElectraDx.
To execute a reverse merger, the defunct parent company, LumiraDx Limited (Cayman Islands), mus...
4
2
$LumiraDx (LMDXF.US)$
To the community following the LumiraDx (LMDXF) restructuring: The legal and financial "smoke" is finally clearing, revealing a surgical "reboot" orchestrated by Ron Zwanziger. Here is the bull case for the ElectraDx play.
By late 2024, the senior secured lenders, BioPharma Credit PLC (BPCR) and its private partner, successfully recovered 96.1% of their $206M investment through a $351.1M asset sale to Roche. This included a $288.4M purchase price for the Poi...
To the community following the LumiraDx (LMDXF) restructuring: The legal and financial "smoke" is finally clearing, revealing a surgical "reboot" orchestrated by Ron Zwanziger. Here is the bull case for the ElectraDx play.
By late 2024, the senior secured lenders, BioPharma Credit PLC (BPCR) and its private partner, successfully recovered 96.1% of their $206M investment through a $351.1M asset sale to Roche. This included a $288.4M purchase price for the Poi...
7
6
$LumiraDx (LMDXF.US)$
To all longs.
(Here is a new SPECULATIVE picture that adds up)
Before Ron Zwanziger’s resignation and the public announcement of the point-of-care (POC) deal with Roche, a comprehensive and highly strategic plan was set in motion to safeguard LumiraDx's core technologies and assets. This process was initiated prior to his stepping down and followed a precise legal framework governed by Cayman Islands law and international corporate restructuring statutes. Under the ...
To all longs.
(Here is a new SPECULATIVE picture that adds up)
Before Ron Zwanziger’s resignation and the public announcement of the point-of-care (POC) deal with Roche, a comprehensive and highly strategic plan was set in motion to safeguard LumiraDx's core technologies and assets. This process was initiated prior to his stepping down and followed a precise legal framework governed by Cayman Islands law and international corporate restructuring statutes. Under the ...
+1
8
$LumiraDx (LMDXF.US)$
speculative information
not legal or financial advice.
Bill Gates’ involvement with LumiraDx reflects his belief in the company’s potential to transform global healthcare, particularly in underserved regions. Through the Bill & Melinda Gates Foundation, Gates has long championed access to affordable, high-quality diagnostics, and LumiraDx’s low-cost, point-of-care platform aligned perfectly with that mission.
His early investment wasn’t just financial—it was a strategi...
speculative information
not legal or financial advice.
Bill Gates’ involvement with LumiraDx reflects his belief in the company’s potential to transform global healthcare, particularly in underserved regions. Through the Bill & Melinda Gates Foundation, Gates has long championed access to affordable, high-quality diagnostics, and LumiraDx’s low-cost, point-of-care platform aligned perfectly with that mission.
His early investment wasn’t just financial—it was a strategi...
6
2
$LumiraDx (LMDXF.US)$
More speculative information.
Not financial or legal advice. Enjoy
IPO
LumiraDx's $5 billion IPO valuation was driven by its innovative point-of-care diagnostic technology, which offered broad testing capabilities, accuracy, and speed particularly with its advanced test strips,
Despite having no sales at the time, the company's technology was seen as highly disruptive in the healthcare sector, promising to revolutionize diagnostics by making testing more ac...
More speculative information.
Not financial or legal advice. Enjoy
IPO
LumiraDx's $5 billion IPO valuation was driven by its innovative point-of-care diagnostic technology, which offered broad testing capabilities, accuracy, and speed particularly with its advanced test strips,
Despite having no sales at the time, the company's technology was seen as highly disruptive in the healthcare sector, promising to revolutionize diagnostics by making testing more ac...
6
$LumiraDx (LMDXF.US)$ A little more research ( still speculation)
On both February 6 and April 1, 2025, over 120 million shares of the stock traded at a consistent price of $0.02, with Yahoo Finance confirming the data is not a glitch. The volume figure, precisely 120,553,903 shares, appeared identically on both dates across different timeframes.
Despite the unusually high volume, there was no significant movement in the stock price, suggesting that these transactions were driven by instit...
On both February 6 and April 1, 2025, over 120 million shares of the stock traded at a consistent price of $0.02, with Yahoo Finance confirming the data is not a glitch. The volume figure, precisely 120,553,903 shares, appeared identically on both dates across different timeframes.
Despite the unusually high volume, there was no significant movement in the stock price, suggesting that these transactions were driven by instit...
+1
5
$LumiraDx (LMDXF.US)$
In Roche’s 2024 financial disclosures, the company reported approximately $4.9 billion in newly allocated goodwill, specifically under the Diagnostics Division. Notably, LumiraDx is the only acquisition explicitly listed for 2024 in that section, and the preliminary cash consideration for that deal was just $353 million, as part of a pre-packaged UK administration sale completed on July 26, 2024.
The documents clearly state that this amount is p...
In Roche’s 2024 financial disclosures, the company reported approximately $4.9 billion in newly allocated goodwill, specifically under the Diagnostics Division. Notably, LumiraDx is the only acquisition explicitly listed for 2024 in that section, and the preliminary cash consideration for that deal was just $353 million, as part of a pre-packaged UK administration sale completed on July 26, 2024.
The documents clearly state that this amount is p...
3
$LumiraDx (LMDXF.US)$ Not how it works Pat...
The statement is incorrect because calling a broker to "remove" shares does not lower the float. The float remains the same unless the company actively buys back shares and cancels them, which is a corporate action, not something a broker can do. When shares are transferred between parties, whether through a broker or on the open market, the total number of outstanding shares remains unchanged. For a payout to increase due to a reduce...
The statement is incorrect because calling a broker to "remove" shares does not lower the float. The float remains the same unless the company actively buys back shares and cancels them, which is a corporate action, not something a broker can do. When shares are transferred between parties, whether through a broker or on the open market, the total number of outstanding shares remains unchanged. For a payout to increase due to a reduce...
3
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)
TheFireStarter OP WAITFOR88 :
TheFireStarter OP M3LANI3 :